{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "La Habra",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "80890",
      "recalling_firm": "Auro Pharmacies, Inc.",
      "address_1": "520 W La Habra Blvd",
      "address_2": "N/A",
      "postal_code": "90631-5308",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in USA",
      "recall_number": "D-1163-2018",
      "product_description": "Testosterone Cypionate/Enanthate injectable, 126/54 mg/mL, packaged in a) 3 mL and b) 5 mL Multiple Dose vials, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631",
      "product_quantity": "43 vials",
      "reason_for_recall": "Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.",
      "recall_initiation_date": "20180821",
      "center_classification_date": "20180829",
      "termination_date": "20200130",
      "report_date": "20180905",
      "code_info": "Lot #: 180709/21, Exp 07-Sep-18"
    }
  ]
}